Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobithron Advance in Knee Osteoarthritis
NCT07323745Phase 1Recruiting
- Sponsor
- Universiti Sains Malaysia
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Mobithron Advance in osteoarthritis (OA), sponsored by Universiti Sains Malaysia. Primary endpoint: Thickness of cartilage in osteoarthritic knee at 52 weeks. Started May 2026; status: recruiting.
02
Drugs
Mobithron Advance
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07323745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07323745.